Treatment of invasive candidiasis in non-haematological patients
Treatment of invasive candidiasis in non-haematological patients Treatment of invasive candidiasis in non-haematological patients
Question3: What’s the problem withthe prediction rules to start empiricaltreatment?1 - High sensitivity, low specificity0%2 - Low sensitivity, high specificity0%3 - Only useful in high incidence areas 0%4 - 1+35 - 2+30%0%
Identification of patients“Ostrosky rules”≥ 4 days on ICUAND-Antibiotics (d 1-3)OR-CVC (d 1-3)And at least 2 of theseTPN (d 1-3)Dialysis (d 1-3)Major surgery (d -7-0)Use steroids (d -7-3)Immunosupp. (d -7-0)Sensitivity 34%, specificity 90%,PPV 1%, NPV 97%Prevalence 7% invasive candidiasisOstrosky-Zeichner, 2007;26:271
- Page 5 and 6: EpidemiologyMainly data from the US
- Page 7 and 8: Survival in candidemia, species rel
- Page 9 and 10: Question1 : Which Candida species i
- Page 11 and 12: Incidence and mortality of Candida
- Page 13 and 14: HOW TO IDENTIFY PATIENTSAT RISK FOR
- Page 15 and 16: Question 2: Which factor has the gr
- Page 17 and 18: Identification of patients“Ostros
- Page 19: Question3: What’s the problem wit
- Page 23 and 24: Are the risk predictive models gene
- Page 25 and 26: Question 4: Empirical treatment is
- Page 27 and 28: HOW TO PREVENT INVASIVECANDIDIASIS
- Page 29 and 30: Empirical antifungal therapy in ICU
- Page 31 and 32: TREATMENT OF INVASIVECANDIDIASIS
- Page 33 and 34: Why do we choose whichantifungal dr
- Page 35 and 36: Randomized Non-Inferior TrialsAmB v
- Page 37 and 38: Caspofungin vs. Amphotericin B tria
- Page 39 and 40: Micafungin vs. L-AmB in ICU Patient
- Page 41 and 42: Anidulafungin vs. fluconazole study
- Page 43 and 44: Success rates different echinocandi
- Page 45 and 46: Question 5: Should the intravascula
- Page 47 and 48: Antifungal agents and survivalCandi
- Page 49 and 50: In conclusion• Invasive candidias
- Page 51 and 52: Treatment of candidemia-Candida spe
- Page 53 and 54: Success at EIV treatment by pathoge
- Page 55 and 56: Question 6: Should the intravascula
- Page 57 and 58: Candida Scorein practiceProspective
Question3: What’s the problem withthe prediction rules to start empiricaltreatment?1 - High sensitivity, low specificity0%2 - Low sensitivity, high specificity0%3 - Only useful <strong>in</strong> high <strong>in</strong>cidence areas 0%4 - 1+35 - 2+30%0%
Change language